key: cord-0875483-f6hn62mp authors: Nagano, H.; Takada, D.; Shin, J.-h.; Morishita, T.; Kunisawa, S.; Imanaka, Y. title: The decrease in hospitalizations for transient ischemic attack and ischemic stroke, especially in mild cases, during the COVID-19 epidemic in Japan. date: 2020-11-18 journal: nan DOI: 10.1101/2020.11.17.20233692 sha: 020d5cdce0b5d4a6ea36d828f6f84613495c8097 doc_id: 875483 cord_uid: f6hn62mp Background and Purpose: The epidemic of the coronavirus disease 2019 (COVID-19) has affected health care systems globally. The aim of our study was to assess the impact of the COVID-19 epidemic on hospital admissions for stroke in Japan. Methods: We analyzed administrative (Diagnosis Procedure Combination) data for cases of inpatients aged 18 years and older who were diagnosed with stroke (ischemic stroke, transient ischemic attack (TIA), hemorrhagic stroke, or subarachnoid hemorrhage (SAH)) and discharged from hospital during the period July 1, 2018 to June 30, 2020. The number of patients with each stroke diagnosis, various patient characteristics, and treatment approaches were compared before and after the epidemic. Changes in the trend of the monthly number of inpatients with each stroke diagnosis were assessed using interrupted time-series analyses. Results: A total of 111,922 cases (ischemic stroke: 74,897 cases; TIA: 5,374 cases; hemorrhagic stroke: 24,779 cases; SAH: 6,872 cases) in 253 hospitals were included. The number of cases for all types of stroke decreased (ischemic stroke: -13.9%; TIA: -21.4%; hemorrhagic stroke: -9.9%; SAH: -15.2%) in April and May 2020, compared to the number of cases in 2019. Ischemic stroke and TIA cases, especially mild cases (modified Rankin Scale = 0), decreased, with a statistically significant change in trend between the before- and after-epidemic periods. Conclusions: These data showed a marked reduction in the number of hospital admissions due to stroke during the COVID-19 epidemic. The change in Ischemic stroke and TIA cases, especially mild cases, was statistically significant. The coronavirus disease 2019 (COVID-19), first recognized in Wuhan, China, in early December 2019[1], spread globally in 2020. In Japan, the daily number of new COVID-19 infections increased dramatically from late March and April 2020 [2] . In response, the Japanese government declared a state of emergency on April 7 for seven prefectures and broadened the declaration to all 47 prefectures on April 16 [3] . Stroke is the second leading cause of death and a major cause of disability in the world [4] . Treatments for stroke, especially intravenous thrombolysis and endovascular intervention for ischemic stroke, are time-sensitive and should be initiated as quickly as possible [5] . Therefore, patients with symptoms suggesting stroke should be evaluated by medical staff immediately. However, movement restrictions and the fear of COVID-19 transmission in hospitals during the COVID-19 epidemic may lead to a hesitation by individuals to seek medical services, resulting in delayed access and a higher risk of severe illness [6] [7] . Although previous studies have shown a decline in hospital admissions for stroke during the COVID-19 epidemic [8] [9] [10] [11] , most of these studies were conducted in a single center or in relatively few centers. In contrast, we performed a retrospective cohort study using a large-scale Japanese database. Our study sought to provide a comprehensive evaluation of the impact of the COVID-19 epidemic on hospital admissions for stroke in Japan. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint For this retrospective cohort study, we extracted Diagnosis Procedure Combination (DPC) data from the Quality Indicator/Improvement Project (QIP) database for inpatients with a date of discharge between July 1, 2018 and June 30, 2020. The QIP database is administered by the Department of Healthcare Economics and Quality Management, Kyoto University [12] , which regularly collects DPC data from acute care hospitals in Japan which voluntarily participate in the project. Over 500 hospitals participate in QIP, covering virtually all of Japan. These hospitals include both public and private facilities of various sizes. In 2019, the number of beds at the participating hospitals ranged from 30 to 1,151 (excluding psychiatric, infectious diseases, and tuberculosis beds according to the Japanese classification of hospital beds). The DPC/per-diem payment system (PDPS) is a Japanese prospective payment system applied to acute care hospitals. In 2018, a total of 1,730 hospitals were using the DPC/PDPS, accounting for 54% (482,618 of 891,872) of all the general hospital beds in Japanese hospitals [13] [14] . The DPC data consist of claims and discharge summaries, including International Classification of Diseases and Related Health problems 10 th Revision (ICD-10) codes classifying the main diagnosis, the cause of hospital admission, the most and second-most medical-resource-intensive diagnoses, up to 10 comorbidities, and 10 complications during hospitalization [15] . The database also includes the following patient . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint details: age, sex, medical procedures, daily records of drug administration, modified Rankin Scale (mRS) before hospital admission and at discharge. We selected cases in which patients aged 18 years and older were hospitalized due to stroke and were discharged between July 1, 2018, and June 30, 2020. Ischemic stroke, transient ischemic attack (TIA), hemorrhagic stroke, and subarachnoid hemorrhage (SAH) were identified by ICD-10 code I63.x, G45.x other than G454, I60.x and I61.x, respectively, as the diagnoses that caused the hospital admission. We began with a descriptive analysis. In order to make year-on-year comparisons, we divided the study population into two groups: those who were admitted and discharged from July 2018 to June 2019 and those who were admitted from July 2019 to June 2020. Because the DPC data were coded on the day of discharge, the data for patients who were not discharged by the end of June 2020 were not available, even though their dates of hospital admissions were before June 30, 2020. Thus, both one-year datasets included inpatient cases that started and ended during the corresponding period. We assessed the monthly ratio of cases with each type of stroke between the two groups. In addition, we compared inpatient is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint An interrupted time series analysis (ITS) was performed to evaluate the effect of the COVID-19 epidemic on the monthly rate of stroke hospitalizations [16] . We statistically tested the changes in the number of admissions based on the date of discharge, after adjusting for seasonality using a Fourier term. We compared the number of admissions per month based on the date of discharge, not the date of admission, in our ITS analyses because, as previously noted, the DPC data were generated after the patient's discharge from the hospitals. We hypothesized that COVID-19 would impact the admissions volume immediately after April 2020, since the Japanese government had declared the state of emergency and requested self-quarantine and social distancing on April 7, 2020, in response . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint to the increasing number of infected cases. All statistical analyses were performed with R version 3.6.0 (R Foundation for Statistical Computing, Vienna, Austria). . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint A total of 111,922 cases (ischemic stroke: 74,897 cases; TIA: 5,374 cases; hemorrhagic stroke: 24,779 cases; SAH: 6,872 cases) in 253 hospitals were included. Among these, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. The ITS analyses indicated that the COVID-19 epidemic had a negative impact on the number of hospitalizations due to ischemic stroke and TIA (p < 0.05) (Figure 3 ). The analyses for ischemic stroke and TIA using the mRS indicated that only the number of inpatients with mRS 0 had been negatively impacted by the COVID-19 epidemic. (Table 3) . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint Estimate: estimated decrease in the number of inpatient cases in the interrupted time series analysis. In this study, we used a large-scale administrative database to show that the number of inpatients due to all types of stroke decreased during the COVID-19 epidemic in Japan. The ITS analyses identified statistically significant decreases in hospitalizations for ischemic stroke and TIA, especially for mild cases in which the mRS scores were 0. The significant decrease in the number of inpatient cases due to ischemic stroke and TIA is consistent with previous reports [17] . In other fields, including pediatrics and cardiology, patients were found to be reluctant to seek medical evaluation for fear of exposure to COVID-19 in hospital [7, 18] . Similarly, patients of stroke, especially those without severe symptoms such as headaches or paralysis, may be hesitant to seek medical services. Another is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint possible explanation for the decrease in the number of inpatients is the lack of contact with others resulting from stay-at home and social distancing practices. In cases of acute stroke, it is not uncommon for friends and neighbors to request emergency help [19] . Even in emergency conditions such as the COVID-19 epidemic, appropriate evaluation and management of stroke is necessary. Any delay in the medical evaluation of even mild cases may result in severe consequences, including long-term disability, pneumonia due to dysphagia, and the early recurrence of stroke. For example, dual antiplatelet therapy within 24 hours of the onset of symptoms decreases the risk of recurrent stroke and death in patients with high-risk TIA or minor ischemic stroke [20] . In the future, healthcare organizations and providers need to recognize that stroke patients with mild symptoms may be reluctant to seek medical evaluation during an epidemic, particularly where "social distancing" and "stay-at-home" practices are being recommended. Those with symptoms suggesting stroke should be encouraged to seek appropriate medical evaluation immediately, even if the symptoms are mild and temporary. Our study has several limitations. First, the study population was restricted to cases in hospitals that voluntarily participate in the QIP. The movement of patients to other, non-participating facilities during the COVID-19 epidemic might lead to an overestimate of . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint the impact of the epidemic. However, in the case of hemorrhagic stroke and SAH, the relatively constant trends of hospitalization identified in the study suggest the absence of large-scale movement to other hospitals. It also suggests a lack of significant restrictions on the acceptance of stroke patients by participating hospitals. Second, our DPC data did not include details of the stroke onset time. Consequently, the period of time from symptom onset to hospital arrival was not assessed. Finally, our research included only cases in Japan. Given the differences in healthcare systems and the patterns of the COVID-19 epidemic between countries, it is difficult to judge whether our results can be applied elsewhere. Despite these limitations, our research provides important information on the impact of the COVID-19 epidemic on stroke patients and the facilities caring for them. We showed a marked reduction in hospital admissions due to stroke during the COVID-19 epidemic in Japan using large-scale administrative data. In particular, our ITS analyses identified a significant reduction in admissions for ischemic stroke and TIA, especially in mild cases. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint Rosenbaum L. The untold toll -The pandemic's effects on patients without covid-19. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233692 doi: medRxiv preprint A novel coronavirus from patients with pneumonia in China Labour and Welfare. Current situation of COVID-19 in Japan Declaration of a State of Emergency in response to the Novel Coronavirus Disease Global Burden of Stroke Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter Decline in stroke alerts and hospitalisations during the COVID-19 pandemic. Stroke Vasc Neurol Decreased Stroke Presentation Rates at a Comprehensive Stroke Center During COVID-19 Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter Study Effects of the per diem prospective payment system with DRG-like grouping system (DPC/PDPS) on resource usage and healthcare quality in Japan New outcome-specific comorbidity scores excelled in predicting in-hospital mortality and healthcare charges in administrative databases Interrupted time series regression for the evaluation of public health interventions: A tutorial Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke during the COVID-19 Era